Michael L. Mihalov
Nessuna posizione attualmente
Profilo
Michael L.
Mihalov has been Medical Director of Prodesse, Inc. since 2004.
He has experience in molecular pathology.
Dr. Mihalov received an undergraduate degree from Wheaton College and an MD from the Loyola University Medical School.
Precedenti posizioni note di Michael L. Mihalov
| Società | Posizione | Fine |
|---|---|---|
Prodesse, Inc.
 Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Direttore Tecnico/Scientifico/R&S | 28/09/2010 |
Formazione di Michael L. Mihalov
| Loyola University of Chicago | Doctorate Degree |
| Wheaton College (Illinois) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Prodesse, Inc.
Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Health Technology |
- Borsa valori
- Insiders
- Michael L. Mihalov
